LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 4 of 15: Mean cell count and mean growth rate across biological replicate 1. - Dataset (ID:20240)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | BI-2536 | 3.33 | uM | LJP6 | 72 | hr | 513 | 740 | 10401 | 0.0711 | 0.0229 |
MCF 10A | BMS345541 | 3.33 | uM | LJP6 | 72 | hr | 513 | 9529 | 10401 | 0.9162 | 0.9119 |
MCF 10A | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 513 | 488 | 10401 | 0.0469 | -0.0026 |
MCF 10A | GDC-0980 | 3.33 | uM | LJP5 | 72 | hr | 513 | 603 | 10401 | 0.0580 | 0.0091 |
MCF 10A | NVP-AEW541 | 3.33 | uM | LJP5 | 72 | hr | 513 | 3020 | 10401 | 0.2904 | 0.2535 |
MCF 10A | SB590885 | 3.33 | uM | LJP5 | 72 | hr | 513 | 9274 | 10401 | 0.8917 | 0.8860 |
MCF 10A | PIK-93 | 3.33 | uM | LJP5 | 72 | hr | 513 | 5421 | 10401 | 0.5213 | 0.4964 |
MCF 10A | KIN001-043 | 3.33 | uM | LJP6 | 72 | hr | 513 | 6085 | 10401 | 0.5850 | 0.5635 |
MCF 10A | Alpelisib | 3.33 | uM | LJP5 | 72 | hr | 513 | 4552 | 10401 | 0.4377 | 0.4085 |
MCF 10A | Luminespib | 3.33 | uM | LJP5 | 72 | hr | 513 | 492 | 10401 | 0.0473 | -0.0021 |
MCF 10A | A443654 | 3.33 | uM | LJP6 | 72 | hr | 513 | 351 | 10401 | 0.0338 | -0.0164 |
MCF 10A | OSI-027 | 3.33 | uM | LJP6 | 72 | hr | 513 | 1101 | 10401 | 0.1059 | 0.0595 |
MCF 10A | XMD11-85h | 3.33 | uM | LJP6 | 72 | hr | 513 | 8668 | 10401 | 0.8334 | 0.8248 |
MCF 10A | HG-6-64-01 | 3.33 | uM | LJP6 | 72 | hr | 513 | 1652 | 10401 | 0.1589 | 0.1152 |
MCF 10A | WH-4-025 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1148 | 10401 | 0.1104 | 0.0642 |
MCF 10A | WZ-4-145 | 3.33 | uM | LJP6 | 72 | hr | 513 | 4150 | 10401 | 0.3990 | 0.3678 |
MCF 10A | XMD16-144 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1297 | 10401 | 0.1247 | 0.0793 |
MCF 10A | Brivanib | 3.33 | uM | LJP5 | 72 | hr | 513 | 4641 | 10401 | 0.4462 | 0.4175 |
MCF 10A | Buparlisib | 3.33 | uM | LJP5 | 72 | hr | 513 | 386 | 10401 | 0.0371 | -0.0129 |
MCF 10A | BX-912 | 3.33 | uM | LJP5 | 72 | hr | 513 | 1326 | 10401 | 0.1275 | 0.0822 |
MCF 10A | Canertinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 694 | 10401 | 0.0668 | 0.0183 |
MCF 10A | Celastrol | 3.33 | uM | LJP6 | 72 | hr | 513 | 450 | 10401 | 0.0433 | -0.0064 |
MCF 10A | CGP60474 | 3.33 | uM | LJP5 | 72 | hr | 513 | 666 | 10401 | 0.0640 | 0.0154 |
MCF 10A | CGP60474 | 3.33 | uM | LJP6 | 72 | hr | 513 | 484 | 10401 | 0.0465 | -0.0030 |
MCF 10A | CHIR-99021 | 3.33 | uM | LJP6 | 72 | hr | 513 | 6115 | 10401 | 0.5880 | 0.5666 |